Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1 1

Status

Completed 28Unknown 21Recruiting 14Active not recruiting 6Terminated 5Not yet recruiting 5Withdrawn 3Enrolling by invitation 1

Sponsor Class

OTHER 4NIH 1

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Thoracic 1Plasma cell 1Other 1Genitourinary 1Classical hematology 1CNS 1

Conditions

Venous Thromboembolism 1Prostatic Neoplasms 1Neuroblastoma 1Neoplasms 1Multiple Myeloma 1Lung Neoplasms 1Dyspnea 1Cardiotoxicity 1Adenocarcinoma of Lung 1

Interventions

Cyclophosphamide 390Carboplatin 344Gemcitabine 332pembrolizumab 329Cisplatin 328Paclitaxel 297Radiotherapy 296Docetaxel 286Bevacizumab 253Rituximab 234Capecitabine 223Nivolumab 220Dexamethasone 206Fluorouracil 190fludarabine 177Oxaliplatin 177Pemetrexed 153Doxorubicin 153Irinotecan 148Leucovorin 144Etoposide 144Cytarabine 133Cetuximab 129Bortezomib 129fludarabine phosphate 128Lenalidomide 126Erlotinib Hydrochloride 120Filgrastim 119Temozolomide 113Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Terminated × Hematologic Tests × Clear all
NCT02780128 2026-03-10

NEPENTHE

Children's Hospital of Philadelphia

Phase 1 Terminated
66 enrolled
CNS

Neoplasms, Neuroblastoma

NCT04827563 2026-03-04

Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib

University of Chicago

Terminated
50 enrolled
OtherPlasma cell

Dyspnea, Multiple Myeloma, Cardiotoxicity

NCT02839681 2019-05-21

Anti-Mesothelin Antibody Drug Conjugate Anetumab Ravtansine for Mesothelin Expressing Lung Adenocarcinoma

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
2 enrolled 12 charts
Thoracic

Adenocarcinoma of Lung, Lung Neoplasms

NCT00523471 2016-02-26

Blood Test to Measure DNA Damage in Blood

AHS Cancer Control Alberta

Terminated
40 enrolled
Genitourinary

Prostatic Neoplasms

NCT01608919 2015-08-10

Predictive Value of Whole Blood Coagulation Parameters for Post-discharge Venous Thromboembolism After Cancer Resection

University of Colorado, Denver

Phase NA Terminated
4 enrolled
Classical hematology

Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡